Furuhata Mitsuaki, Takayama Tadahiro, Yamamoto Takanobu, Ozawa Yasumasa, Senoo Motoki, Ozaki Manami, Yamano Seiichi, Sato Shuichi
Division of Applied Oral Sciences, Nihon University Graduate School of Dentistry, Tokyo, Japan.
Department of Periodontology, Nihon University School of Dentistry, Tokyo, Japan.
J Dent Sci. 2021 Oct;16(4):1170-1181. doi: 10.1016/j.jds.2021.03.008. Epub 2021 Apr 3.
BACKGROUND/PURPOSE: Fibroblast growth factor-2 (FGF-2) regulates bone formation. The concept of guided bone regeneration using a resorbable collagen membrane (RCM) is generally accepted in implant dentistry. This study aimed to investigate the bone healing pattern in rat mandibular bone defects in real-time with and without RCM containing FGF-2 (RCM/FGF-2).
Critical-size circular bone defects (4.0 mm diameter) were created on both sides of the rat mandibular bone. The defects were randomly divided into the following groups: control, RCM alone, RCM containing low (0.5 μg) or high (2.0 μg) concentration of FGF-2. We performed real-time in vivo micro-computerized tomography scans at the baseline and at 2, 4, and 6 weeks, and measured the volume of newly formed bone (NFB), bone mineral density (BMD) of NFB, and the closure percentage of the NFB area. At 6 weeks, the mandibular specimens were assessed histologically and histomorphometrically to evaluate the area of new bone regeneration.
Real-time assessment revealed a significant increase in the volume, BMD, and closure percentage of the NFB area in the RCM/FGF-2-treated groups than that in the control and RCM groups. In the H-FGF-2 group, the volume and BMD of NFB exhibited a significant increase at 6 weeks than that at the baseline. Histological evaluation revealed the presence of osteoblasts, osteocytes, and blood vessels within the NFB.
The real-time in vivo experiment demonstrated that RCM/FGF-2 effectively promoted bone regeneration within the critical-size mandibular defects in rats and verified new bone formation starting in the early postoperative phase.
背景/目的:成纤维细胞生长因子-2(FGF-2)调节骨形成。在种植牙科中,使用可吸收胶原膜(RCM)引导骨再生的概念已被广泛接受。本研究旨在实时观察大鼠下颌骨缺损在使用和不使用含FGF-2的RCM(RCM/FGF-2)情况下的骨愈合模式。
在大鼠下颌骨两侧制造临界尺寸的圆形骨缺损(直径4.0毫米)。缺损随机分为以下几组:对照组、单纯RCM组、含低浓度(0.5μg)或高浓度(2.0μg)FGF-2的RCM组。在基线以及术后2、4和6周进行实时体内微型计算机断层扫描,并测量新形成骨(NFB)的体积、NFB的骨矿物质密度(BMD)以及NFB区域的闭合百分比。在6周时,对下颌骨标本进行组织学和组织形态计量学评估,以评价新骨再生面积。
实时评估显示,与对照组和RCM组相比,RCM/FGF-2治疗组的NFB区域体积、BMD和闭合百分比显著增加。在高浓度FGF-2(H-FGF-2)组,NFB的体积和BMD在6周时比基线时显著增加。组织学评估显示NFB内存在成骨细胞、骨细胞和血管。
实时体内实验表明,RCM/FGF-2能有效促进大鼠临界尺寸下颌骨缺损内的骨再生,并证实术后早期即开始有新骨形成。